Press Releases

MAPLE GROVE, Minn. and SAN FRANCISCO, Dec. 3, 2019 /PRNewswire/ -- StemoniX, Inc. and

BOSTON, Dec. 3, 2019 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processing, today announced that Proteostasis management will present at the Piper Jaffray 31s

SAN DIEGO, Dec. 3, 2019 /PRNewswire/ -- Decipher Biosciences, a leader in the field of urologic cancer genomics, today announced that Palmetto GBA, a Medicare Administrative Contractor (MAC), issued a final local coverage determination (LCD) for use of Decipher® Prostate Biopsy in men diagnosed with favorable and unfavorable intermediate-risk prostate cancer.

CHICAGO, Dec. 3, 2019 /PRNewswire/ -- The Blue Cross Blue Shield Association (BCBSA) announced today that David L. Holmberg, president and chief executive officer of Highmark Health, has been elected chairman of the BCBSA Board of Directors. BCBSA is the national federation of 36 independent, community-based and locally operated Blue C

ROCKVILLE, Md., Dec. 3, 2019 /PRNewswire/ -- A new national poll of more than 1,100 parents of children under age 18 finds that seven in 10 parents are concerned about their child developing hearing damage from listening to popular technology devices such as music players, tablets, and smartphones—and 86% think their children listen to their devices at volumes

AUSTIN, Texas, Dec. 3, 2019 /PRNewswire/ -- Two-thirds of Americans (66%) say becoming a grandparent is an important milestone to them, while a third of parents (33%) worry their children may suffer from infertility in the future.* These are among the findings in recent surveys commissioned by

COLUMBIA, S.C., Dec. 3, 2019 /PRNewswire/ -- Heart of Hospice, LLC has announced the purchase of the operations of Heartstrings Hospice. Stephen Shroyer, President and Owner of Heartstrings Hospice: "Heartstrings Hospice has compassionately served patients and families throughout South Carolina's midland reg

SAN DIEGO, Dec. 3, 2019 /PRNewswire/ -- Viriom Inc (Viriom) announces launching Segment I and Segment II reproductive toxicity studies of Elpida® (elsulfavirine) HIV-1 therapy, supported by preclinical services of the

First patient successfully dosed in QBiotics' Phase I/II clinical trial of tigilanol tiglate in patients with Head and Neck Squamous Cell Carcinoma (HNSCC) Tigilanol tiglate is a novel, small molecule that is being tested as a single injection treatment for solid tumours The Phase I/II clinical trial is a dose escalation study in HNSCC patients designed to determine optimal dosage, safety and tumou

CHICAGO, Dec. 3, 2019 /PRNewswire/ -- Focused ultrasound is a safe and effective way to target and open areas of the blood-brain barrier, potentially allowing for new treatment approaches to Alzheimer's disease, according to initial study results presented at the annual meeting of the Radiological Society of North America (RSNA).